Showing results (151-160 of 178) with videos related to
Sort By:
Pageof 18
Diagnostic Microbiology and Infectious Disease|November 7, 2017
Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassaysChristophe Pasquier, Guillaume Joguet, Catherine Mengelle, et al.Gynecologie, Obstetrique & Fertilite|March 11, 2011
[Teratozoospermia, myth or reality? A 10-years retrospective study on 101404 consecutive sperm samples]N Prisant, P Cohen-Bacrie, E Amar, et al.Journal of Clinical Pharmacology|February 1, 1990
Biochemical, endocrine, and mineral effects of indapamide in black womenL M Prisant, S P Beall, G E Nichoalds, et al.Acta Crystallographica. Section D, Structural Biology|March 14, 2018
Model validation: local diagnosis, correction and when to quitJane S Richardson, Christopher J Williams, Bradley J Hintze, et al.Magnetic Resonance Imaging|January 1, 1993
Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiographyJ D Allison, F W Flickinger, J C Wright, et al.Journal of Clinical Pharmacology|February 1, 1991
Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging studyA A Carr, P B Bottini, L M Prisant, et al.Journal of Clinical Pharmacology|March 1, 1991
Mexiletine versus quinidine as first-line antiarrhythmia therapy: results from consecutive trialsM J Frank, L O Watkins, L M Prisant, et al.Journal of Clinical Pathology|February 16, 2020
MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry studyIrina Marin, Efrat Ofek, Jair Bar, et al.The American Journal of Cardiology|January 15, 1992
Morphologic, hemodynamic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemiaJ L Houghton, A A Carr, L M Prisant, et al.American Heart Journal|August 1, 1995
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatmentL M Prisant, M R Weir, V Papademetriou, et al.Pageof 18